Event Details
European Atherosclerosis Society 93rd Congress (EAS 2025)
May 4 - May 7, 2025
Title: PALISADE: Plozasiran decreases the risk of acute pancreatitis (AP) and may improve quality of life (QOL) in familial chylomicronemia syndrome (FCS)
Session: Lipid Lowering Therapies and Advances in Vascular Therapeutics
Date/Time: May 5, 2025, 13:30-14:30 BST
Presenter: Gerald Watts
Title: Zodasiran (ARO-ANG3), an investigational rnai therapeutic, demonstrates profound and durable reductions in LDL-cholesterol, apolipoprotein B, and ANGPTL3 in patients with HoFH; Gateway final results
Session: Late Breaker Session: Clinical
Date/Time: May 7, 2025, 11:00-12:30 BST
Presenter: Fredrick J. Raal